(1) Oscillococcinum
Posted: Fri Feb 28, 2020 1:15 pm
OSCILLOCOCCINUM
https://www.natlawreview.com/article/ni ... u-symptoms (2018)
OSCILLOCOCCINUM
http://www.ritecare.com/homeopathic/gui ... lococcinum
Oscillococcinum is a 200c potency of an autolysate of Barbary duck heart and liver.
Double blind placebo controlled study in 1987 during a Flu outbreak:
Was given to those with rectal temperature of 38°C (100.4°F)or above, and at least two of the following symptoms: headache, stiffness, lumbar or articular pain and shivers.
The first manifestations had to have occurred less than 24 hours before the study.
After 48 hours, 17% of the active treatment group had fully recovered, compared to 10% of the placebo group. This difference was statistically significant (p=0.03, X2 test). Further analysis showed that the effect of Oscillococcinum peaked at 36 hours,
when 40% of recoveries were attributable to the treatment. It was most effective in younger patients - 68% of recoveries within 48 hours in the under-30’s were due to treatment; and when the illness was relatively mild - 52% of the recoveries from illnesses classified mild or moderate were due to treatment. Patients on active treatment used significantly less other treatment for pain and fever (50% v 41%, p=0.04), they also judged the active treatment more efficacious than placebo (61% v 49% p=0.02).
The Lancet commented favorably on the trial, remarking that the authors were restrained in their discussion, and describing the difference between placebo and active treatment as “respectable”. The Lancet’s report was “quadruple-blind” mentioning only at the very end that the treatment was homoeopathic.
https://www.natlawreview.com/article/ni ... u-symptoms (2018)
OSCILLOCOCCINUM
http://www.ritecare.com/homeopathic/gui ... lococcinum
Oscillococcinum is a 200c potency of an autolysate of Barbary duck heart and liver.
Double blind placebo controlled study in 1987 during a Flu outbreak:
Was given to those with rectal temperature of 38°C (100.4°F)or above, and at least two of the following symptoms: headache, stiffness, lumbar or articular pain and shivers.
The first manifestations had to have occurred less than 24 hours before the study.
After 48 hours, 17% of the active treatment group had fully recovered, compared to 10% of the placebo group. This difference was statistically significant (p=0.03, X2 test). Further analysis showed that the effect of Oscillococcinum peaked at 36 hours,
when 40% of recoveries were attributable to the treatment. It was most effective in younger patients - 68% of recoveries within 48 hours in the under-30’s were due to treatment; and when the illness was relatively mild - 52% of the recoveries from illnesses classified mild or moderate were due to treatment. Patients on active treatment used significantly less other treatment for pain and fever (50% v 41%, p=0.04), they also judged the active treatment more efficacious than placebo (61% v 49% p=0.02).
The Lancet commented favorably on the trial, remarking that the authors were restrained in their discussion, and describing the difference between placebo and active treatment as “respectable”. The Lancet’s report was “quadruple-blind” mentioning only at the very end that the treatment was homoeopathic.